Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Dr S M Eason 19/04/2013 Dr S J Murray 19/04/2013 15 December 2025 The principal activity of the LLP during the financial year was that of a medical practice. SO304396 2025-03-31 SO304396 bus:Director1 2025-03-31 SO304396 bus:Director2 2025-03-31 SO304396 core:CurrentFinancialInstruments 2025-03-31 SO304396 core:CurrentFinancialInstruments 2024-03-31 SO304396 2024-03-31 SO304396 core:Non-currentFinancialInstruments 2025-03-31 SO304396 core:Non-currentFinancialInstruments 2024-03-31 SO304396 core:OtherPropertyPlantEquipment 2024-03-31 SO304396 core:OtherPropertyPlantEquipment 2025-03-31 SO304396 2024-04-01 2025-03-31 SO304396 bus:FilletedAccounts 2024-04-01 2025-03-31 SO304396 bus:SmallEntities 2024-04-01 2025-03-31 SO304396 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 SO304396 bus:LimitedLiabilityPartnershipLLP 2024-04-01 2025-03-31 SO304396 bus:Director1 2024-04-01 2025-03-31 SO304396 bus:Director2 2024-04-01 2025-03-31 SO304396 core:OtherPropertyPlantEquipment core:TopRangeValue 2024-04-01 2025-03-31 SO304396 2023-04-01 2024-03-31 SO304396 core:Non-currentFinancialInstruments 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: SO304396 (Scotland)

TERRA NOVA MEDICAL PRACTICE LLP

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH THE REGISTRAR

TERRA NOVA MEDICAL PRACTICE LLP

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025

Contents

TERRA NOVA MEDICAL PRACTICE LLP

BALANCE SHEET

AS AT 31 MARCH 2025
TERRA NOVA MEDICAL PRACTICE LLP

BALANCE SHEET (continued)

AS AT 31 MARCH 2025
Note 2025 2024
£ £
Current assets
Debtors 4 58,519 43,962
Cash at bank and in hand 183,988 97,715
242,507 141,677
Creditors: amounts falling due within one year 5 ( 95,383) ( 27,025)
Net current assets 147,124 114,652
Total assets less current liabilities 147,124 114,652
Creditors: amounts falling due after more than one year 6 ( 3,294) 0
Net assets attributable to members 143,830 114,652
Represented by
Loans and other debts due to members within one year
Other amounts 143,830 114,652
143,830 114,652
Members' other interests
0 0
143,830 114,652
Total members' interests
Loans and other debts due to members 143,830 114,652
143,830 114,652

For the financial year ending 31 March 2025 the LLP was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

Members' responsibilities:

Terra Nova Medical Practice LLP has no equity and, in accordance with the provisions contained within the Statement of Recommended Practice "Accounting by Limited Liability Partnerships", has not presented a Statement of Changes in Equity.

The financial statements of Terra Nova Medical Practice LLP (registered number: SO304396) were approved and authorised for issue by the Board of Directors on 15 December 2025. They were signed on its behalf by:

Dr S M Eason
Designated member
TERRA NOVA MEDICAL PRACTICE LLP

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
TERRA NOVA MEDICAL PRACTICE LLP

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Terra Nova Medical Practice LLP is a limited liability partnership, incorporated in the United Kingdom under the Limited Liability Partnerships Act 2000 and is registered in Scotland. The address of the LLP's registered office is Terra Nova House, 43 Dura Street, Dundee, DD4 6SW, United Kingdom.

The financial statements have been prepared under the historical cost convention and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Limited Liability Partnerships Act 2000 as applicable to companies subject to the small companies regime and the requirements of the Statement of Recommended Practice Accounting by Limited Liability Partnerships issued in December 2021 (SORP 2022).

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The members have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The members have a reasonable expectation that the LLP has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover represents amounts earned during the year from medical activities.

If, at the balance sheet date, completion of contractual obligations is dependent on external factors (and thus outside the control of the Limited Liability Partnership), then revenue is recognised only when the event occurs. In such cases, costs incurred up to the balance sheet date are carried forward as work in progress.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised as an expense when the LLP is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Defined contribution schemes
The LLP operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

The taxation payable on the partnership's profits is the personal liability of the members, although payment of such liabilities is administered by the partnership on behalf of its members. Consequently, neither partnership taxation nor related deferred taxation is accounted for in these financial statements. Sums set aside in respect of members' tax obligations are included in the balance sheet within loans and other debts due to members, or are set against amounts due from members as appropriate.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Non-financial assets
At each balance sheet date, the LLP reviews its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss.

If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

Where it is not possible to estimate the recoverable amount of an individual asset, the LLP estimates the recoverable amount of the cash-generating unit to which the asset belongs. An impairment loss is recognised immediately in profit or loss.

Financial assets
An asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

For financial assets carried at amortised cost, the amount of impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks.

Financial instruments

Financial assets and financial liabilities are recognised when the LLP becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the LLP after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the LLP intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs.

Basic financial liabilities
Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less.

Members' participation rights

Members' participation rights are the rights of a member against the LLP that arise under the members' agreement (for example, in respect of amounts subscribed or otherwise contributed, remuneration and profits).

Members’ participation rights in the earnings or assets of the LLP are analysed between those that are, from the LLP's perspective, either a financial liability or equity, in accordance with section 22 of FRS 102. A member’s participation rights including amounts subscribed or otherwise contributed by members, for example members’ capital, are classed as liabilities unless the LLP has an unconditional right to refuse payment to members, in which case they are classified as equity.

The profits are automatically divided as they arise or are determined, so that the LLP does not have an unconditional right to refuse payment, the amounts arising that are due to members are in the nature of liabilities. They should therefore be treated as an expense in the profit and loss account in the relevant year and, to the extent they remain unpaid at the year end, they should be shown as liabilities in the balance sheet. This will also be the case where there is a requirement to divide some or all profits but the basis upon which those profits are shared between individual members is not determined until after the balance sheet date, as a liability exists even if the identity of the recipients have not yet been determined.

All amounts due to members that are classified as liabilities are presented in the Statement of Financial Position within 'Loans and other debts due to members' and are charged to the Profit and Loss Account within 'Members' remuneration charged as an expense'. Amounts due to members that are classified as equity are shown in the Statement of Financial Position within 'Members' other interests'.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the LLP during the year 13 14

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 April 2024 36,541 36,541
At 31 March 2025 36,541 36,541
Accumulated depreciation
At 01 April 2024 36,541 36,541
At 31 March 2025 36,541 36,541
Net book value
At 31 March 2025 0 0
At 31 March 2024 0 0

4. Debtors

2025 2024
£ £
Trade debtors 0 10,678
Other debtors 58,519 33,284
58,519 43,962

5. Creditors: amounts falling due within one year

2025 2024
£ £
Other creditors 95,383 27,025

6. Creditors: amounts falling due after more than one year

2025 2024
£ £
Other creditors 3,294 0

There are no amounts included above in respect of which any security has been given by the small entity.